Neoplastic meningitis medical therapy: Difference between revisions

Jump to navigation Jump to search
 
(9 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Neoplastic meningitis}}
{{Neoplastic meningitis}}
{{familytree/start |summary=Treatment of neoplastic meningitis}}
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | | | | | | | A01| | | | | | | | | | | | | |A01=<div style="width: 12em; padding:0.2em;">'''Treatment of neoplastic meningitis'''</div>}}
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | |,|-|-|-|v|-|^|-|v|-|-|-|.| | | | | | | | | | | | | | |}}
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | B01 | | B02 | | B03 | | B04 | | | | | | | | | | | | | |B01=<div style="width: 9em; padding:0.2em;">'''Intrathecal<br>chemotherapy<br>''' </div>|B02=<div style="width: 9em; padding:0.2em;">'''Radiotherapy'''</div>|B03=<div style="width: 9em; padding:0.2em;">'''Surgery'''</div>||B04=<div style="width: 9em; padding:0.2em;">'''Supportive care'''</div>}}
{{familytree/end}}
{{CMG}}{{AE}}{{SR}}
{{CMG}}{{AE}}{{SR}}


==Overview==
==Overview==
The mainstay of therapy for neoplastic meningitis is [[intrathecal chemotherapy]].<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>
The mainstay of therapy for neoplastic meningitis is [[intrathecal chemotherapy]].<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref> [[Radiotherapy]] may be used in patients with neoplastic meningitis for palliation of symptoms, reduce the bulky tumors, and correction of cerebrospinal fluid flow abnormalities.<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref> Supportive care should be directed towards all patients with neoplastic meningitis, regardless of the treatment regimen ([[anticonvulsants]], [[corticosteroids]], and [[opiates]]).<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>


==Medical Therapy==
==Medical Therapy==
The various treatment options for neoplastic meningitis include:<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>
The various treatment options for neoplastic meningitis include:<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>


{{familytree/start |summary=Treatment of neoplastic meningitis}}
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | | | | | A01 | | | | | | | | | | | | | |A01=<div style="width: 12em; padding:0.2em;">'''Treatment of neoplastic meningitis'''</div>}}
{{familytree |boxstyle=background: #DCDCDC;| | | | | | |,|-|-|-|-|+|-|-|-|-|.| | | | | | | | | | | | | |}}
{{familytree |boxstyle=background: #DCDCDC;| | | | | | B01 | | | B02 | | | B03 | | | | | | | | | | | |B01=<div style="width: 9em; padding:0.2em;">'''Intrathecal<br>chemotherapy<br>''' </div>|B02=<div style="width: 9em; padding:0.2em;">'''Radiotherapy'''</div>|B03=<div style="width: 9em; padding:0.2em;">'''Surgery'''</div>}}
{{familytree/end}}




Line 19: Line 19:
*The mainstay of therapy for neoplastic meningitis is [[intrathecal chemotherapy]].<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>
*The mainstay of therapy for neoplastic meningitis is [[intrathecal chemotherapy]].<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>
*Chemotherapy can help in treatment of the total involved [[neuraxis]]. It may be administered systemically or intrathecally.
*Chemotherapy can help in treatment of the total involved [[neuraxis]]. It may be administered systemically or intrathecally.
*Chemotherapy given via systemic route has poor CSF penetration, hence intrathecal chemotherapy is the preferred mode of administration.
*Chemotherapeutic drugs can be given intrathecally either by lumbar puncture or via an intraventricular reservoir system.
*Chemotherapeutic drugs can be given intrathecally either by lumbar puncture or via an intraventricular reservoir system.
*Accessing via the intraventricular reservoir system is preferred to lumbar puncture for the following reasons:
*Accessing via the intraventricular reservoir system is preferred to lumbar puncture for the following reasons:<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>
:*Simple procedure
:*Simple procedure
:*More comfortable for the patient
:*More comfortable for the patient
:*Safer than repeated lumbar punctures
:*Safer than repeated lumbar punctures
:*Better uniform distribution of the drug in the subarachnoid space
:*Better uniform distribution of the drug in the subarachnoid space
*Chemotherapeutic agents that are routinely used include:<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>
:*[[Methotrexate]]
:*[[Cytarabine]]
:*[[Thiotepa]]
===Radiotherapy===
*[[Radiotherapy]] may be used in patients with neoplastic meningitis.<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>
*Indications for radiotherapy include:<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>
:*Palliation of symptoms, such as [[cauda equina syndrome]]
:*to reduce the bulky tumors, especially the coexistent parenchymal intracerebral metastases
:*correction of cerebrospinal fluid flow abnormalities
===Supportive Care===
Supportive care should be directed towards all patients with neoplastic meningitis, regardless of the treatment regimen.<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>
*[[Anticonvulsants]]: administered to the patients who have a [[seizure]].
*[[Corticosteroids]]: usually [[dexamethasone]], given 4-10 mg every 4-6 h, can reduce peritumoral [[edema]] and lower intracranial pressure with a decrease in symptoms ([[headache]] or [[drowsiness]]).
*[[Opiates]]: pain medication


==References==
==References==
Line 36: Line 54:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Neurology]]
[[Category:Neurosurgery]]

Latest revision as of 19:05, 12 August 2019

Neoplastic meningitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neoplastic Meningitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neoplastic meningitis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neoplastic meningitis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neoplastic meningitis medical therapy

CDC on Neoplastic meningitis medical therapy

Neoplastic meningitis medical therapy in the news

Blogs on Neoplastic meningitis medical therapy

Directions to Hospitals Treating Choroid plexus papilloma

Risk calculators and risk factors for Neoplastic meningitis medical therapy

 
 
 
 
 
 
 
 
 
 
 
 
Treatment of neoplastic meningitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intrathecal
chemotherapy
 
Radiotherapy
 
Surgery
 
Supportive care
 
 
 
 
 
 
 
 
 
 
 
 
 

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

The mainstay of therapy for neoplastic meningitis is intrathecal chemotherapy.[1] Radiotherapy may be used in patients with neoplastic meningitis for palliation of symptoms, reduce the bulky tumors, and correction of cerebrospinal fluid flow abnormalities.[1] Supportive care should be directed towards all patients with neoplastic meningitis, regardless of the treatment regimen (anticonvulsants, corticosteroids, and opiates).[1]

Medical Therapy

The various treatment options for neoplastic meningitis include:[1]


Chemotherapy

  • The mainstay of therapy for neoplastic meningitis is intrathecal chemotherapy.[1]
  • Chemotherapy can help in treatment of the total involved neuraxis. It may be administered systemically or intrathecally.
  • Chemotherapy given via systemic route has poor CSF penetration, hence intrathecal chemotherapy is the preferred mode of administration.
  • Chemotherapeutic drugs can be given intrathecally either by lumbar puncture or via an intraventricular reservoir system.
  • Accessing via the intraventricular reservoir system is preferred to lumbar puncture for the following reasons:[1]
  • Simple procedure
  • More comfortable for the patient
  • Safer than repeated lumbar punctures
  • Better uniform distribution of the drug in the subarachnoid space
  • Chemotherapeutic agents that are routinely used include:[1]

Radiotherapy

  • Radiotherapy may be used in patients with neoplastic meningitis.[1]
  • Indications for radiotherapy include:[1]
  • Palliation of symptoms, such as cauda equina syndrome
  • to reduce the bulky tumors, especially the coexistent parenchymal intracerebral metastases
  • correction of cerebrospinal fluid flow abnormalities

Supportive Care

Supportive care should be directed towards all patients with neoplastic meningitis, regardless of the treatment regimen.[1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 Chamberlain, M. C. (2008). "Neoplastic Meningitis". The Oncologist. 13 (9): 967–977. doi:10.1634/theoncologist.2008-0138. ISSN 1083-7159.


Template:WikiDoc Sources